BACKGROUND: Emergency contraception (EC) can prevent pregnancy but is under-used. Advanced provision increases use but the effect on contraceptive behaviour varies. METHODS: Women aged 18 -45 years, using less effective contraceptives, were randomized to either advanced provision of three courses of EC (intervention) or to obtaining each course from clinic (control). EC use and contraceptive behaviour were monitored for 1 year. RESULTS: In all, 1030 women were recruited in 6 months. The mean 6 SD number of courses of EC used in intervention versus control group was 0.56 6 1.2 versus 0.20 6 0.6 (P < 0.001). In the intervention group, 47% women aged <26 years used at least one course of EC compared with 23% of older women (P < 0.001). The majority of women used condoms before (intervention 89%, control 91%) and during the study (89% for both groups). Consistency of contraceptive use was higher during the study (65 versus 60% of women in both groups) (P < 0.001). There were 17 unplanned pregnancies, eight in the intervention group, six of whom did not use EC in the conception cycle. CONCLUSIONS: Advanced provision increases EC use especially among young women in Hong Kong. Contraceptive choice and consistency of use remains the same even among young women.
Introduction
Emergency contraception (EC) prevents pregnancy. Increased use of EC is widely regarded as a solution to increasing rates of unintended pregnancy and abortion (Hayes et al., 2000; Jones et al., 2002) . Hormonal EC is more likely to prevent pregnancy if used soon after intercourse (Task Force on Postovulatory Methods of Fertility Regulation, 1998), so the inevitable delay involved in obtaining it may reduce its effectiveness. Modern hormonal EC is safe (World Health Organization, 1998 ) and easy to use. Giving women a supply of EC pills to keep at home so that they have them when EC is needed, is enthusiastically supported as a strategy to increase use. Six studies, undertaken in four countries, have demonstrated that advanced provision of EC is associated with increased use (Glasier and Baird, 1998; Lovvorn et al., 2000; Raine et al., 2000; Ellertson et al., 2001; Jackson et al., 2003; Glasier et al., 2004) . All but one of these studies demonstrated that advanced provision of EC did not influence the use of other, more reliable contraceptives. The one study that did suggest an influence on use of other methods was among younger women (aged 16 -24 years) and demonstrated a trend towards less frequent use of more effective methods of contraception in the group given EC to keep at home (Raine et al., 2000) . The behaviour of women in different countries with different ethnic, cultural and social backgrounds is likely to vary. With this in mind, we conducted a randomized controlled trial of advanced provision of EC to women attending family planning clinics in Hong Kong. The aims of our study were to evaluate how women behave if given a supply of EC to keep at home, whether they use it correctly and whether there are differences in the way young women behave compared with older women.
Materials and methods

Study design
Women were recruited between September 1, 2001 and February 28, 2002 from a Youth Health Care Centre (YHCC) for unmarried women aged ,26 years and from a Birth Control Clinic (BCC) for married women of all ages and unmarried women aged $ 26 years. Women between 18 and 45 years old using less effective contraceptive methods (condom, spermicide, natural family planning, withdrawal or nothing) were invited to participate. Subjects were randomized in blocks of 10 using a computer-generated randomization list. The allocation for each study subject was concealed in an opaque, labelled and sealed envelope. Study numbers were assigned sequentially to each consecutive subject agreeing to participate and the respective envelope was subsequently opened to reveal the study allocation. Subjects were contacted by telephone every 3 months for follow-up, and clinic visits were arranged if required. The study was approved by the Ethics Panel of the Family Planning Association of Hong Kong (FPAHK) which ran both clinics. Written informed consent for participation was obtained from each subject.
Recruitment and study procedure All women agreeing to participate in the trial were educated about EC and given an information sheet to keep and completed a form recording demographic details.
Women randomized to the control group were instructed to attend the clinic for EC whenever they needed it. Women in the intervention group were given three courses of Norlevo w (two tablets of 0.75 mg levonorgestrel; HRA Pharma Laboratorie, France) to keep at home. They were instructed (verbally and in writing) to take one tablet of levonorgestrel as soon as possible within 72 h after a single episode of unprotected intercourse, and the second tablet 12 h later. If they used all three courses of EC, women in the intervention group were asked to attend the clinic for counselling about regular contraception. Three more courses of levonorgestrel were dispensed, if appropriate. If all six courses were used, no further supplies of study drug were dispensed but the follow-up continued until the end of the study.
All women were instructed to return to the clinic for a pregnancy test if menses was overdue by . 1 week following EC use. If the pregnancy test was positive, women who chose to have the pregnancy terminated were given the option to remain in the study whereas those who chose to continue the pregnancy were withdrawn.
Outcomes measured
The primary objective was to study how women behave when given EC to keep at home. The two outcomes measured were the number of course(s) of EC used and the use of other methods of contraception (contraceptive behaviour). Contraceptive behaviour was assessed in terms of changes in method use (switching), consistency of contraceptive use and the frequency of unprotected intercourse.
The secondary objective was to assess whether women could selfadminister EC correctly. The outcomes measured included the timing of taking the first pill, whether it was taken after a single episode of unprotected intercourse or contraceptive failure (or after more than one episode), and whether the second dose was taken 12 h later. Although the study was not powered to detect a significant difference in pregnancy rates between the two groups of women, the rates were recorded.
All women were asked to keep a diary of contraceptive use (including EC) and sexual intercourse. They were contacted every 3 months by telephone. The contraceptive method and consistency of use, the number of acts of intercourse and the number of episodes of EC use each month and any pregnancies were documented during the phone call.
Women with a supply of EC at home were instructed to complete a drug intake record whenever they used EC. The record sheet was either mailed to the principal investigator after completion (33 forms), or kept until the next follow-up contact when the details were given to the researcher over the telephone. The record documented the reason for using EC, the date of the last menstrual period, the timing and number of episodes of unprotected intercourse or contraceptive accidents in that cycle, the time when EC was taken and whether pregnancy had resulted or not.
The same drug intake record was collected for women in the control group if they attended the clinic for EC, or if EC was obtained from another provider.
Statistical analysis
The number of women requesting EC in the YHCC each month is 20%. Based on these data it was estimated that , 20% of women would use EC at least once a year. A 10% increase in the use of EC resulting from advanced provision was regarded as clinically significant. The sample size necessary to achieve 90% power, with a significant difference at the 5% level, was estimated to be 389 women in each arm of the study. Assuming 20% drop-out, the target sample size for each arm was 490. Recruitment was continued until the end of February despite reaching the target sample size in mid February. The final number of subjects recruited was 515 in each arm.
SPSS (version 11.5 for Windows) was used for statistical analysis. Descriptive statistics were presented for demographic factors. The pattern of EC use and the significance of any difference were tested with x 2 -test for trend. Student's t-test was used to compare mean age, parity and previous number of abortions between the intervention and control groups. McNemar's test was used to test for changes in contraceptive behaviour over time in all women. P , 0.05 was statistically significant.
Results
Rate of refusal
The total number of women asked to participate and the number refusing was recorded during the first 3 months of recruitment. Forty per cent of women from the BCC refused to participate in the study. The main reasons for refusing to participate were perceived lack of need for EC because of successful use of contraception in the past, age or a desire to become pregnant. In the YHCC, 13% of young women refused to participate. The main reasons were an unwillingness to be contacted regularly or lack of time to hear about the study.
Study subjects
A total of 1030 women were recruited during the study period, 750 from the BCC and 280 from the YHCC. Of 515 women randomized to the control group, 487 subjects (94.6%) completed 12 months follow-up, 15 defaulted and 13 withdrew. In the intervention group, 499 subjects (96.9%) completed 12 months follow-up, eight defaulted and eight withdrew. The reasons for withdrawal are shown in Figure 1 . The baseline demographic characteristics and reproductive histories did not differ between the two groups of women. Of the women recruited from the BCC, 85.9% were married compared with none of those recruited from the YHCC. The number of episodes of EC used during the 6 months before the study started was also similar for both groups of women (P ¼ 0.377) ( Table I) .
Primary outcome: number of courses of EC pill used
Women who had a supply to keep at home were more likely to use EC than those who had to attend a clinic to obtain it. In an intention-to-treat analysis using all available data, including data from those who defaulted or withdrew, the mean^SD number of episodes of EC use was 0.56^1.21
Advanced provision of emergency contraception by women in the intervention group (n ¼ 515, data from 500 women) and 0.20^0.59 in the control group (n ¼ 515, data from 492 women) (P , 0.001). Similar results were obtained when the analysis was performed only in subjects who had completed 12 months of follow-up [0.56^1.21 episodes in the intervention group (n ¼ 499) versus 0.20^0.58 episodes in the control group (n ¼ 487), P , 0.001]. When compared with the mean number of episodes of EC use during the 6 months prior to the start of the study, use among the control group was unchanged (0.20 episodes for both time periods). In contrast, use of EC among the women who had a supply at home had trebled (0.17 episodes before the study versus 0.56 episodes during it).
The pattern of EC use during the year of follow-up is summarized in Table II . Twice as many women (n ¼ 149, 29.9%) in the intervention group had used at least one course of EC compared with women in the control group (n ¼ 63, 12.9%). Women with a supply of EC at home used almost three times more EC than women who had to attend the clinic. The difference in the pattern of use was statistically significant (P , 0.001).
EC use differed between women attending the BCC (n ¼ 722, mean age 36.0^5.5) and the YHCC (n ¼ 264, mean age 22.2^2.1 years) who had completed 12 months follow-up. In both age groups, women who had EC at home were significantly more likely to use it than those who did not (P , 0.001). Given a home supply, young women were more likely to use it than older women (P , 0.001). In both age groups, 11% of women who had to obtain it from a clinic used EC during 12 months of follow-up. Twenty-three per cent of women aged $ 26 years who had a supply at home used EC during the year of follow up compared with 47% of women aged , 26 years (P , 0.001). Younger women also used EC more often than older women if they had a supply at home. The mean^SD number of cycles of EC used by women recruited from the BCC who had a supply of EC at home (n ¼ 363) was 0.39^0.88 compared with 0.15^0.48 among women who had to attend the clinic for supplies (n ¼ 359). This difference was significant (P , 0.001). The mean^SD number of cycles of EC used by YHCC subjects in the intervention group (n ¼ 136) was 0.99^1.74 and in the control group (n ¼ 128) was 0.32^0.79. The young women with a supply of EC at home had the highest proportion of EC use during the 1 year follow-up period, 47% of women using EC. Two women recruited from the YHCC and given a supply of EC to keep at home used more than six courses (Table III) .
Primary outcome: contraceptive behaviour
Six months before the study started, the condom was the commonest contraceptive method used among women of all ages (91.1% of women from the control group and 89.1% from the intervention group were using condoms). Six months after the study started, the pattern of condom use was the same in both groups, with 89% of women in each group using condoms. Throughout the 1 year of follow-up, patterns of contraceptive use remained consistent among both age groups (Table IV) . The reported choice of contraceptive was not different between the two groups of women either before or during the study. However, women in both groups claimed to be using contraception more consistently during the study (65% every month) when compared with use before the study started (60%). This difference was statistically significant (P , 0.001).
The reasons for using EC are listed in Table V . Women who had a supply of EC at home were more likely to use it following an act of unprotected intercourse (rather than following a contraceptive accident) than women who had to attend the clinic to obtain EC (P , 0.001).
Secondary outcome: correctness of EC pill administration
An intention-to-treat analysis was performed on all available data from the drug intake records, including data from women who defaulted or withdrew from the study. Out of the 373 courses of EC used in this way, 302 (81%) completed records and 37 incomplete records were received.
Data for the time of intercourse and time the first pill was taken were available in 327 records (95 from the control group and 232 from the intervention group). With only one exception, all the women used EC within 72 h of intercourse. Women who had a supply at home used EC significantly sooner after intercourse than women who had to attend a clinic to obtain it. The mean^SD time interval from intercourse to first dose taken was 28.5^19.8 h for the control group and 13.9^14.4 h for the intervention group (P , 0.001).
All subjects in the control group took the second dose correctly, i.e. 12 h after the first dose. In the intervention group, 38 subjects out of 229 (16.6%) did not take it correctly.
There were 321 records (84.3%) with the number of episodes of intercourse prior to EC use documented. On 284 occasions (88.5%) EC was used after a single act of unprotected intercourse or contraceptive failure. There were 37 episodes (15 from the group who had to obtain EC from a clinic versus 22 from the group who had EC at home, P ¼ 0.110) when EC was taken after more than one episode of unprotected intercourse or contraceptive accident. One of these women conceived.
Secondary outcome: pregnancy rate
The pregnancy rate was similar in both groups. There were nine unplanned intrauterine pregnancies in nine women from the control group and none of them had used EC in the cycle in which conception occurred. They did not take EC because four of them thought that the risk of becoming pregnant was low that time, four believed that the contraceptives they used were successful and one could not obtain EC. In the intervention group, there were eight unplanned intrauterine pregnancies in seven subjects. Five women, including the one who became pregnant twice, did not take EC despite having a supply at home. The main reasons for not taking EC on the six occasions were again perceived low risk of getting pregnant (four women) and two believed that the contraceptives were successful. Out of 373 cycles in which EC was used, there were two pregnancies, a rate of 0.54%. 
Advanced provision of emergency contraception
The 95% confidence interval for the odds ratio for pregnancy was 0.28-2.05.
Discussion
This study confirms the finding of a number of others, undertaken in a variety of settings: Scotland (Glasier and Baird, 1998; Glasier et al., 2004) , Ghana (Lovvorn et al., 2000) , India (Ellertson et al., 2001 ) and the USA (Jackson et al., 2003) -that advanced provision of EC increases its use. Women given a supply of EC to keep at home were almost three times more likely to use it than women who had to attend a clinic to obtain EC. As in Scotland (Glasier et al., 2004) , and in Ghana (Lovvorn et al., 2000) women who had EC at home also tended to use it much sooner after intercourse, potentially increasing the likelihood of preventing pregnancy. Most of the women who took EC without seeing a health professional (intervention group) took the first dose within 72 h; however, 17% of them did not take the second dose at the correct time. Since a single dose of 1.5 mg levonorgestrel appears to be as effective as two separate doses of 0.75 mg levonorgestrel (von Hertzen et al., 2002) , women can now be advised to take the two pills together which facilitate compliance. Easier access to EC does not appear, among this population of women, to lead to repeated use. Only a few women appeared to rely on EC for contraception. Only 13 women used more than three courses in 1 year. Admittedly, some women might have used more had they been given more than three courses at the start of the study, nevertheless only 25 (3%) used all three courses. The two young women who used it more than six times obtained the additional courses from elsewhere, suggesting that it was not advanced provision per se which encouraged repeated use.
Women who had a supply of EC at home used it on 71% of occasions following unprotected intercourse. In contrast, only just over half the women who had to attend the clinic for supplies had had unprotected intercourse, the rest using it after an accident with their contraceptive method. It is possible that some women who had EC at home had unprotected sex, intending to use EC as a planned post-coital contraceptive. There is no evidence, however, from the data collected at follow-up, that women in the intervention group used condoms less consistently than women in the control group, and other studies have not shown any increase in risk-taking behaviour. If easier access to EC encouraged less consistent contraceptive use, one might also have expected more pregnancies in the intervention group. It is possible that women who had to see a health professional to obtain EC were reluctant to admit to having unprotected sex and so claimed that a condom had been used even when it had not.
The Hong Kong study is the first to give advanced supplies of levonorgestrel; all the earlier studies offered the Yuzpe regimen of EC. Since the latter contains estrogen and is associated with a much higher incidence of side-effects, particularly nausea and vomiting (Task Force on Postovulatory Methods of Fertility Regulation, 1998), there was some concern among the investigators that the use of a bettertolerated regimen of EC might be associated with more Condom  323  326  101  97  314  315  91  93  308  318  83  90  307  305  84  90  Calendar  5  9  3  4  5  7  3  3  5  11  2  2  5  10  3  2  Withdrawal  1  4  4  4  1  5  3  3  1  7  2  5  1  6  4  7  Spermicide  2  3  0  0  2  3  0  0  2  3  0  0 repeated use. This does not seem to have happened. In the Hong Kong study, 30% women from the intervention group used EC at least once compared with 47% in the Scotland study (Glasier and Baird, 1998) , which involved a similar number of women. Giving women a supply of EC to keep at home did not appear to affect their use of more effective methods of regular contraception. This was the case even for the women aged , 26 years. This is in contrast to the findings of a study undertaken among women aged 16-24 years in California (Raine et al., 2000) where women given EC in advance of need tended to use less effective regular methods of contraception and to use their method less consistently. While both of the Scottish studies (Glasier and Baird, 1998; Glasier et al., 2004) showed a clear trend with time for women to change from condoms to hormonal contraception, women in Hong Kong stuck with condoms. Indeed the consistency of method use during the year of follow-up is quite remarkable and contrasts with patterns of method-switching in other populations (Grady et al., 2002) . Condoms are a very popular method of contraception in Hong Kong (Glasier et al., 2003) . In this setting, improved access to EC does not appear to undermine the use of barrier methods of contraception. This finding will be reassuring to those who express concern that easier access to EC will lead to an increase in unsafe sex, and thereby an increase in sexually transmitted infections including HIV/AIDS (Stammers, 2001; Bissell and Anderson, 2003) .
Although a randomized trial, the study has several limitations. Young unmarried women attending the clinic were more likely to agree to participate in the study than the older women. This may reflect the fact that different investigators were responsible for recruitment in the two clinics. It is more likely, however, that the older women did not perceive themselves as likely to need to use EC and therefore did not want it to keep at home. In assessing coital frequency, contraceptive behaviour and correct use of EC, we tried to minimize recall bias by asking women to keep a record of their behaviour. The data were gathered during the telephone follow-up but very few record forms were returned to the investigators. We designed the follow-up record to include some questions which would allow cross-validation of the responses. We found a reassuringly high reliability of responses to all the questions, but we do acknowledge that probably not all women kept complete or accurate records. Some will have relied on recall of events, but as follow-up was every 3 months it is likely that the data, at least for contraceptive use, were reasonably reliable. We were also aware of the possibility that behavioural change in this kind of observational study may be attributable to confounding factors such as participation in the study. It is almost certainly for this reason that contraceptive use was reported to be more consistent during the study than before it began. Moreover, tightly controlled studies of this nature may not truly represent how women would behave were they not participating in a research project. A strength of the study, however, lies in the fact that all the women were recruited, informed about EC, and followed up, by one of only two investigators.
Only two other studies of advanced provision of EC have looked at the effect on abortion. The first (Glasier and Baird, 1998) suggested a non-significant trend towards a reduction in unintended pregnancies. A much larger (but nonrandomized) intervention study in the same setting (Glasier et al., 2004) , however, failed to show any effect on abortion rates. Both Scottish studies used the Yuzpe regimen of EC. Levonorgestrel is thought to be more effective, but we too were unable in this study to demonstrate any difference in pregnancy rates between the control and intervention groups. As in the Scottish study (Glasier et al., 2004) , most of the women who conceived despite having a supply of EC to use, failed to recognize any risk of pregnancy and so failed to use EC. Out of the 17 unplanned pregnancies, only two had used EC.
In conclusion, advanced provision of EC to women attending a family planning service in Hong Kong demonstrated increased use of EC, without appearing to encourage repeated use or the abandonment of their regular contraceptives. Despite having a supply at home, most women who had an unintended pregnancy during the study did not use EC. The results suggest, however, that advanced provision of EC as a public health strategy to reduce unintended pregnancy may prove disappointing.
